Anlon Healthcare Subscription Day 3
Posted by : sachet | Fri Aug 29 2025
Here, Anlon Healthcare launched on 26th August 2025. The issue will be closed for bidding today, on 29th August 2025. The primary aim of Anlon Healthcare is to raise ₹121.03 crores from the market. Additionally, Anlon Healthcare has received an impressive level of subscription, which suggests that the shares will be listed at a remarkable premium. Scroll down to check the Anlon Healthcare subscription and details.
Anlon Healthcare Details
| IPO Open Date | 26th August 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹86 to 91 per share |
| Lot Size | 164 Shares |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE and NSE |
| IPO Close Date | 29th August 2025 |
| Listing Date | 3rd September 2025 |
The price band for Anlon Healthcare has been prescribed as ₹86 to ₹91 per share, with a total of 1,33,00,000 shares issued. Let’s segregate the share quota fixed for different categories of investors.
| Categories | Shares Offered | % Shares offered |
| QIB Shares Offered | 99,75,000 | 0.00% |
| NII (HNI) Shares Offered | 19,95,000 | 15.00% |
| Retail Investors | 13,30,000 | 10.00% |
| Total Shares Offered | 1,33,00,000 | 100.00% |
Anlon Healthcare Subscription Status
As of now, Anlon Healthcare has been subscribed to 6.42 times. Of these, 42.91 times are subscribed by retail investors, 8.87 times by non-institutional investors, and 1.06 times by QII (Qualified Institutional Investors).
The healthy subscription status indicates that investors are expecting higher returns at the time of the Anlon Healthcare listing on 3rd September 2025. Anlon Healthcare also has a positive outlook behind the fresh issue of 1.33 crore shares, which is expected to raise around Rs 121.03 crore.
Anlon Healthcare GMP Today
We know that higher subscription prices encourage grey market premiums for IPOs. Let’s explore the Anlon Healthcare GMP for 29th August 2025.
The grey market premium for this IPO is 5.49% or Rs 2 per share. It indicates that the estimated listing price per share is Rs 93. Numerous factors played a pivotal role in this jump in Anlon Healthcare’s IPO GMP. These include higher subscription rates received, positive market sentiments, and investors’ positive attitude towards IPOs.
About Anlon Healthcare Ltd.
Anlon Healthcare Limited is a chemical manufacturing company specialising in the production of high-purity, advanced pharmaceutical intermediates, which serve as raw materials or key starting materials in the manufacture of active pharmaceutical ingredients. The company also undertakes API development, preparation, and filing of Drug Master Files (DMFs) in the Indian and global markets, as per the pharmacopoeia requirements of customers and regulatory agencies. In addition to manufacturing pharma intermediates and APIs in accordance with various domestic and international standards, we have recently begun offering custom manufacturing services for complex or novel chemical compounds. We tailor the manufacturing process to meet specific customer requirements, including producing chemicals with purity levels that exceed industry standards.
Financial Performance
Assess the company’s financial performance over the past three years to gauge expectations for the Anlon Healthcare listing.
| Year Ended | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
| Assets | 181.30 | 128.00 | 111.55 |
| Revenue | 120.46 | 66.69 | 113.12 |
| Profit After Tax | 20.52 | 9.66 | 5.82 |
| EBITDA | 32.38 | 15.57 | 12.66 |
| Net Worth | 80.42 | 21.03 | 7.37 |
| Reserve and surplus | 40.57 | 5.03 | -4.63 |
| Total Borrowing | 58.35 | 74.56 | 66.39 |
Explanation
Anlon Healthcare Limited’s revenue increased by 81% from ₹66.69 crores in March 2024 to ₹120.46 crores in March 2025. Moreover, the company’s PAT rose by 112% from ₹9.66 crores to ₹20.52 crores.
Technical Indicators
Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of Anlon Healthcare.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 17.67 |
| EPS (Earnings Per Share) | 5.15 |
| RoNW | 25.51 |
| ROCE | 21.93 |
| ROE | 40.45 |
| EBITDA Margin | 26.88 |
| Price to Book Value | 4.51 |
| Market Capitalisation | ₹483.68 Cr |
Anlon Healthcare Listing Expectations
Anlon Healthcare: IPO allotment is still pending. However, according to current GMP or market sentiments, it is reasonable to expect higher listing gains from the share. A 2.20% jump in Anlon Healthcare GMP suggests that the estimated listing price per share will be approximately Rs 93.
It will provide higher listing gains to investors who applied for this IPO. Additionally, the financial fundamentals of this business made it the experts’ top long-term recommendations.
Anlon Healthcare Dates
| IPO Open Date | 26th August 2025 |
| IPO Close Date | 29th August 2025 |
| Allotment | 1st September 2025 |
| Refund Date | 2nd September 2025 |
| IPO Listing Date | 3rd September 2025 |
Note: IPO GMP is highly volatile, influenced by market sentiment. Hence, one should conduct their research before investing in it.
Recent Articles
Droom IPO Details: Everything You Should Know about
Upcoming IPO: Optivalue Tek Consulting, Goel Construction Co, Austere Systems
Best Stocks Under ₹100 in 2025 for Potential Returns
White Organic Retail Q1 Results FY26: Q1 PAT Fall 194.39% to -₹1.77 Crore; Revenue Up -% YoY
Prabhat Technologies Q1 Results FY26: Q1 PAT Fall 34.09% to -₹0.76 Crore; Revenue Up 93.95% YoY
Related Posts
Anlon Healthcare IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Vikran Engineering IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Current Infraprojects IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Sattva Engineering Construction IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Sneha Organics IPO GMP: Day 1 IPO Live Updates
